Centiva Capital LP Has $1.38 Million Stake in National Health Investors, Inc. (NYSE:NHI)

Centiva Capital LP grew its holdings in National Health Investors, Inc. (NYSE:NHI) by 52.8% during the third quarter, Holdings Channel.com reports. The firm owned 16,410 shares of the real estate investment trust’s stock after buying an additional 5,667 shares during the period. Centiva Capital LP’s holdings in National Health Investors were worth $1,379,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Edgestream Partners L.P. raised its position in National Health Investors by 135.6% during the third quarter. Edgestream Partners L.P. now owns 78,088 shares of the real estate investment trust’s stock valued at $6,564,000 after acquiring an additional 44,938 shares in the last quarter. Verition Fund Management LLC bought a new position in National Health Investors during the third quarter valued at approximately $293,000. Martingale Asset Management L P bought a new position in National Health Investors during the third quarter valued at approximately $1,921,000. Waterfront Capital Partners LLC bought a new position in National Health Investors during the third quarter valued at approximately $10,097,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in National Health Investors by 332.0% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 242,326 shares of the real estate investment trust’s stock valued at $20,370,000 after acquiring an additional 186,238 shares in the last quarter. Institutional investors and hedge funds own 62.51% of the company’s stock.

National Health Investors Trading Down 0.6 %

Shares of National Health Investors stock opened at $75.55 on Thursday. The company’s fifty day simple moving average is $78.42 and its 200-day simple moving average is $75.02. The company has a market cap of $3.43 billion, a price-to-earnings ratio of 25.96, a PEG ratio of 5.10 and a beta of 1.04. The company has a current ratio of 10.29, a quick ratio of 10.29 and a debt-to-equity ratio of 0.92. National Health Investors, Inc. has a 1 year low of $51.59 and a 1 year high of $86.13.

National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.42). The company had revenue of $63.32 million during the quarter, compared to analyst estimates of $67.93 million. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The company’s revenue was up 1.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.08 EPS. As a group, sell-side analysts expect that National Health Investors, Inc. will post 4.42 EPS for the current year.

National Health Investors Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 29th. Stockholders of record on Tuesday, December 31st will be paid a $0.90 dividend. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.60 annualized dividend and a dividend yield of 4.77%. National Health Investors’s payout ratio is 123.71%.

Analysts Set New Price Targets

Several brokerages recently weighed in on NHI. StockNews.com lowered shares of National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, October 15th. Truist Financial lifted their price target on shares of National Health Investors from $65.00 to $78.00 and gave the company a “hold” rating in a research report on Friday, August 30th. Wells Fargo & Company lowered shares of National Health Investors from an “overweight” rating to an “equal weight” rating and lifted their price target for the company from $81.00 to $86.00 in a research report on Tuesday, October 1st. Finally, Bank of America started coverage on shares of National Health Investors in a research report on Tuesday, September 24th. They issued a “buy” rating and a $92.00 price target on the stock. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat, National Health Investors currently has a consensus rating of “Moderate Buy” and an average target price of $76.33.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.